Menu

Vascular Biogenics Ltd. VBLT

Full chart Compare
Set alert

Price alert · VBLT

All alert types
0.16 +0.16

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $634.00KExpenses → Selling, General & Admin: $11.75MExpenses → Research & Development: $21.65MExpenses → Interest Expense: $85.00KGross Profit → Expenses: $554.00KRevenue → Gross Profit: $554.00KRevenue → Cost of Revenue: $104.00KNet Loss → Expenses: $32.30MOther Income$634.00KGross Profit$554.00KNet Loss$32.30MCost of Revenue$104.00KExpenses$33.49MSelling, General & Admin$11.75MResearch & Development$21.65MInterest Expense$85.00KRevenue$658.00K

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

VBLT annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
658.00K768.00K922.00K562.00K585.00K
658.00K768.00K922.00K562.00K585.00K
104.00K365.00K394.00K222.00K255.00K
554.00K403.00K528.00K340.00K330.00K
33.41M30.40M25.01M20.42M21.57M
21.65M22.70M19.66M14.71M15.18M
11.75M7.70M5.36M5.71M6.40M
-32.85M-30.00M-24.48M-20.08M-21.25M
85.00K44.00K105.00K184.00K159.00K
-32.30M-29.92M-24.23M-19.40M-20.50M
-32.30M-29.92M-24.23M-19.40M-20.50M
-32.30M-29.92M-24.23M-19.40M-20.50M
-32.30M-29.92M-24.23M-19.40M-20.50M
0.420.450.550.540.62
0.420.450.550.540.62
0.420.450.550.540.62
-32.22M-29.88M-24.12M-19.21M-20.34M
-32.22M-29.88M-24.12M-19.21M-20.34M
77.55M66.35M43.67M35.88M32.97M
77.55M66.35M43.67M35.88M32.97M